Lyell Immunopharma (LYEL) Cash from Financing Activities (2020 - 2026)
Lyell Immunopharma's Cash from Financing Activities came in at $522,000 for Q2 2026, up 185.2% from $183,000 a year earlier but down 99.0% from the prior quarter.
Lyell Immunopharma (LYEL) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Lyell Immunopharma reported Cash from Financing Activities of $102.47 million; for FY2025, it came in at $50.41 million.
- Cash from Financing Activities carries a five-year compound annual growth rate of -36.2% (FY2020 to FY2025).
- Going back by year, Cash from Financing Activities was $1.33 million in FY2024 (-23.9%), $1.74 million in FY2023 (-83.6%), $10.64 million in FY2022 (-97.3%) and $401.24 million in FY2021 (-15.8%).
- The five-year range for quarterly Cash from Financing Activities is -$531,000 (Q3 2021) to $51.72 million (Q1 2026).
- Year-over-year, Cash from Financing Activities increased in 1 of the last five quarters, with an average decline of 16.3%.
- The fastest year-over-year change in Cash from Financing Activities over five years came in Q1 2022 (growth of 189.0%), and the weakest in Q2 2022 (a decline of 99.4%).
- Business Quant data shows LYEL's Cash from Financing Activities at $51.72 million (Q1 2026), $222,000 (Q4 2025) and $50 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Lyell Immunopharma | 229.06 Mn | 229.06 Mn | - | 522,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 522,000.00 |
| Mar 31, 2026 | 51.72 Mn |
| Dec 31, 2025 | 222,000.00 |
| Sep 30, 2025 | 50.00 Mn |
| Jun 30, 2025 | 183,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 437,000.00 |
| Jun 30, 2024 | 862,000.00 |
| Mar 31, 2024 | 27,000.00 |
| Dec 31, 2023 | 759,000.00 |
| Sep 30, 2023 | -143,000.00 |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | -69,000.00 |
| Dec 31, 2022 | 863,000.00 |
| Sep 30, 2022 | 4.76 Mn |
| Jun 30, 2022 | 2.46 Mn |
| Mar 31, 2022 | 2.56 Mn |
| Dec 31, 2021 | 7.40 Mn |
| Sep 30, 2021 | -531,000.00 |
| Jun 30, 2021 | 393.49 Mn |
Lyell Immunopharma Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=LYEL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();